Ashland (NYSE:ASH – Get Free Report) issued its quarterly earnings results on Wednesday. The basic materials company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.28 by ($0.02), Briefing.com reports. The company had revenue of $522.00 million during the quarter, compared to the consensus estimate of $524.07 million. Ashland had a net margin of 7.01% and a return on equity of 5.98%. The company’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter last year, the firm posted $0.41 earnings per share. Ashland updated its FY 2025 guidance to EPS.
Ashland Trading Down 7.6 %
Shares of ASH traded down $6.68 during trading hours on Thursday, reaching $80.70. 1,535,852 shares of the company traded hands, compared to its average volume of 419,448. Ashland has a 12-month low of $71.55 and a 12-month high of $102.50. The firm has a market cap of $3.94 billion, a price-to-earnings ratio of 27.56, a PEG ratio of 1.13 and a beta of 0.88. The stock’s fifty day moving average price is $86.31 and its 200 day moving average price is $91.74. The company has a current ratio of 2.98, a quick ratio of 1.84 and a debt-to-equity ratio of 0.45.
Ashland Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Sunday, September 15th. Stockholders of record on Sunday, September 1st were given a $0.405 dividend. The ex-dividend date was Friday, August 30th. This represents a $1.62 annualized dividend and a dividend yield of 2.01%. Ashland’s dividend payout ratio is 54.92%.
Analysts Set New Price Targets
Read Our Latest Analysis on ASH
About Ashland
Ashland Inc provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions.
Featured Articles
- Five stocks we like better than Ashland
- How Can Investors Benefit From After-Hours Trading
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- EV Stocks and How to Profit from Them
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Investing in Construction Stocks
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Ashland Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ashland and related companies with MarketBeat.com's FREE daily email newsletter.